{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:04:01Z","timestamp":1791821041378,"version":"4.3.4"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14552-8","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T07:51:09Z","timestamp":1751615469000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Paediatric acute myeloid leukaemia epidemiology, treatment approaches, and outcomes in africa: A review of the literature"],"prefix":"10.1186","volume":"25","author":[{"given":"Richard","family":"Nyeko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Kruger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nixon","family":"Niyonzima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verhulst","family":"Stijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaques","family":"van Heerden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"key":"14552_CR1","doi-asserted-by":"publisher","unstructured":"Barbara Deschler M, L\u00fcbbert. Acute Myeloid Leukemia: Epidemiology and Etiology. CANCER 2006, 107(9):2099\u20132107. https:\/\/doi.org\/10.1002\/cncr.22233.","DOI":"10.1002\/cncr.22233"},{"key":"14552_CR2","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2007.1.453","author":"RichardA Larson","year":"2007","unstructured":"Larson Richard A. Etiology and management of therapy-related myeloid leukemia. Hematology. 2007. https:\/\/doi.org\/10.1182\/asheducation-2007.1.453.","journal-title":"Hematology"},{"issue":"03","key":"14552_CR3","first-page":"01","volume":"10","author":"K Gnanavel","year":"2022","unstructured":"Emmanuel Ifeanyi Obeagu, Gnanavel K. An insight on acute myeloid leukaemia: pediatric perspective. Int J Innovative Appl Res. 2022;10(03):01\u20138.","journal-title":"Int J Innovative Appl Res"},{"key":"14552_CR4","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1111\/bjh.14617","volume":"177","author":"E Molyneux","year":"2017","unstructured":"Molyneux E, Scanlan T, Chagaluka G, Renner L. Haematological cancers in African children: progress and challenges. Br J Haematol. 2017;177:971\u20138. https:\/\/doi.org\/10.1111\/bjh.14617.","journal-title":"Br J Haematol"},{"key":"14552_CR5","doi-asserted-by":"publisher","unstructured":"Romy EV, Weelderen K, Klein MD, Natawidjaja R, De Vries, Gertjan JL, Kaspers. Outcome of pediatric acute myeloid leukaemia (AML) in low- and middle-income countries: a systematic review of the literature. Expert Review of Anticancer Therapy 2021, 21(7):765\u2013780, https:\/\/doi.org\/10.1080\/14737140.14732021.11895756.","DOI":"10.1080\/14737140.14732021.11895756"},{"key":"14552_CR6","volume-title":"SEER cancer statistics review, 1975\u20132009","author":"N Howlader","year":"2012","unstructured":"Howlader N, Noone AM, Krapcho M. SEER cancer statistics review, 1975\u20132009. Bethesda, MD: National Cancer Institute; 2012."},{"key":"14552_CR7","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3332\/ecancer.2014.478","volume":"8","author":"CK Williams","year":"2014","unstructured":"Williams CK, Foroni L, Luzzatto L, Saliu I, Levine A, Greaves MF. Childhood leukaemia and lymphoma: African experience supports a role for environmental factors in leukaemogenesis. Ecancermedicalscience. 2014;8:478.","journal-title":"Ecancermedicalscience"},{"key":"14552_CR8","doi-asserted-by":"publisher","unstructured":"Reedijk AMJ, Klein K, Coebergh JWW, Kremer LC, Dinmohamed AG, de Haas V et al. Improved survival for children and young adolescents with acute myeloid leukemia: a Dutch study on incidence, survival and mortality. Leukemia 2018, 33(6):1349\u20131359. https:\/\/doi.org\/10.1038\/s41375-41018-40314-41377.","DOI":"10.1038\/s41375-41018-40314-41377"},{"issue":"1","key":"14552_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1182\/blood-2013-02-484097","volume":"122","author":"U Creutzig","year":"2013","unstructured":"Creutzig U, Zimmermann M, Bourquin JP. al. e: randomized trial comparing liposomal Daunorubicin with Idarubicin as induction for pediatric acute myeloid leukemia: results from study AML-BFM 2004. Blood. 2013;122(1):37\u201343.","journal-title":"Blood"},{"issue":"1","key":"14552_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamaoncol.2021.5206","volume":"118","author":"MA Kutny","year":"2021","unstructured":"Kutny MA, Alonzo TA, Abla O, Rajpurkar M, Gerbing RB, Yi-Cheng W, et al. Assessment of arsenic trioxide and All-trans retinoic acid for the treatment of pediatric acute promyelocytic Leukemia - A report from the children\u2019s oncology group AAML1331 trial. JAMA Oncol. Nov 2021;118(1):1\u20139. https:\/\/doi.org\/10.1001\/jamaoncol.2021.5206.","journal-title":"JAMA Oncol"},{"key":"14552_CR11","doi-asserted-by":"publisher","unstructured":"Klein K, De Haas V, Kaspers GJL. Clinical challenges in de novo pediatric acute myeloid leukemia. Expert Rev Anticancer Ther 2018,;18(3):277\u2013293. https:\/\/doi.org\/10.1080\/14737140.14732018.11428091.","DOI":"10.1080\/14737140.14732018.11428091"},{"issue":"27","key":"14552_CR12","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1200\/JCO.2015.62.8289","volume":"33","author":"CM Zwaan","year":"2015","unstructured":"Zwaan CM, Kolb EA, Reinhardt D, et al. Collaborative efforts driving progress in pediatric acute myeloid leukemia. J Clin Oncol. 2015;33(27):2949\u201362.","journal-title":"J Clin Oncol"},{"key":"14552_CR13","doi-asserted-by":"publisher","unstructured":"van Weelderen RE, Njuguna F, Klein K et al. Outcomes of paediatric acute myeloid leukaemia treatment in Western Kenya. Cancer Reports 2021, 5(10):e1576. https:\/\/doi.org\/10.1002\/cnr1572.1576.","DOI":"10.1002\/cnr1572.1576"},{"issue":"2","key":"14552_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3322\/caac.21219","volume":"64","author":"E Ward","year":"2014","unstructured":"Ward E, DeSantis C, Robbins A, et al. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83\u2013103. 110.3322\/caac.21219.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"14552_CR15","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1016\/j.ejca.2013.03.024","volume":"49","author":"S Gupta","year":"2013","unstructured":"Gupta S, Yeh S, Martiniuk A, Lam CG, Heui-Yang C, Liu Y-L, et al. The magnitude and predictors of abandonment of therapy in paediatric acute leukaemia in middle-income countries: a systematic review and meta-analysis. Eur J Cancer. Jul; 2013;49(11):2555\u201364. DOI:2510.1016\/j. ejca.2013.2503.2024.","journal-title":"Eur J Cancer"},{"issue":"7","key":"14552_CR16","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1080\/143140.1432021.1189556","volume":"21","author":"RE Van Weelderen","year":"2021","unstructured":"Van Weelderen RE, Klein K, Natawidjaja MD, De Vries R, Kaspers GJ. Outcome of paediatric acute myeloid leukaemia (AML) in low- and middle-income countries: a systematic review of the literature. Expert Rev Anticancer Ther. 2021;21(7):765\u201380. 710.1080\/14737140.14732021.11895756.","journal-title":"Expert Rev Anticancer Ther"},{"key":"14552_CR17","doi-asserted-by":"publisher","unstructured":"van Weelderen RE, Njuguna F, Klein K et al. Outcomes of pediatric acute myeloid leukemia treatment in Western Kenya. Cancer Reports 2022, 5(10):e1576. https:\/\/doi.org\/10.1002\/cnr1572.1576.","DOI":"10.1002\/cnr1572.1576"},{"key":"14552_CR18","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1002\/pbc.24576","volume":"60","author":"E Kersten","year":"2013","unstructured":"Kersten E, Scanlan P, DuBois SG, Matthay KK. Current treatment and outcome for childhood acute leukemia in Tanzania. Pediatr Blood Cancer. 2013;60:2047\u201353. DOI 2010.1002\/pbc.24576.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"14552_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.5897\/AJHST2023.0021","volume":"5","author":"D Oyamo","year":"2023","unstructured":"Oyamo D, Arega G. Clinical characteristics and induction outcome of pediatric acute myeloid leukemia (AML) patients treated at tertiary referral hospital, addis ababa,ethiopia: a retrospective cross-sectional study. Afr J Health Sci Technol. 2023;5(3):19\u201325. https:\/\/doi.org\/10.5897\/AJHST2023.0021.","journal-title":"Afr J Health Sci Technol"},{"issue":"4","key":"14552_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/MPH.0000000000001408","volume":"41","author":"HA Hafez","year":"2019","unstructured":"Hafez HA, Soliaman RM, Bilal D, Hashem M, Shalaby LM. Early deaths in pediatric acute leukemia: a major challenge in developing countries. J Pediatr Hematol Oncol. 2019;41(4):261\u20136.","journal-title":"J Pediatr Hematol Oncol"},{"key":"14552_CR21","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3109\/08880018.2011.601435","volume":"28","author":"SP Yadav","year":"2011","unstructured":"Yadav SP, Ramzan M, Lall M, Sachdeva A. Paediatric acute myeloid leukaemia: the final frontier for paediatric oncologists in developing world. Pediatr Hematol Oncol. 2011;28:647\u20138.","journal-title":"Pediatr Hematol Oncol"},{"issue":"10","key":"14552_CR22","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/j.ejca.2010.03.002","volume":"46","author":"T Israels","year":"2010","unstructured":"Israels T, Damen CWN, Cole M, et al. Malnourished Malawian patients presenting with large Wilms tumours have a decreased vincristine clearance rate. Eur J Cancer. 2010;46(10):1841\u20137.","journal-title":"Eur J Cancer"},{"key":"14552_CR23","doi-asserted-by":"publisher","unstructured":"Romy EV, Weelderen K, Klein MD, Natawidjaja R, De Vries, Gertjan JL, Kaspers. Outcome of pediatric acute myeloid leukemia (AML) in low- and middle-income countries: a systematic review of the literature. Expert Rev Anticancer Ther 2021:https:\/\/doi.org\/10.1080\/14737140.14732021.11895756","DOI":"10.1080\/14737140.14732021.11895756"},{"key":"14552_CR24","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"14552_CR25","doi-asserted-by":"publisher","unstructured":"Creutzig U, Van Den Heuvel-eibrink MM, Gibson B, Dworzak MN, Adachi S, de Bont E et al. Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel. Blood 2012,18;120(6):3187\u20133205. https:\/\/doi.org\/10.1182\/blood-2012-3103-362608.","DOI":"10.1182\/blood-2012-3103-362608"},{"issue":"9","key":"14552_CR26","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.ejca.2011.10.009","volume":"48","author":"S Gupta","year":"2012","unstructured":"Gupta S, Bonilla M, Valverde P, Fu L, Howard SC, Ribeiro RC, et al. Treatment-related mortality in children with acute myeloid leukaemia in Central America: incidence, timing and predictors. Eur J Cancer. 2012;48(9):1363\u20139.","journal-title":"Eur J Cancer"},{"issue":"4","key":"14552_CR27","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/MPH.0000000000000319","volume":"37","author":"MS Weaver","year":"2015","unstructured":"Weaver MS, Howard SC, Lam CG. Defining and distinguishing treatment abandonment in patients with cancer. J Pediatr Hematol Oncol. 2015;37(4):252\u20136. https:\/\/doi.org\/10.1097\/MPH.0000000000000319.","journal-title":"J Pediatr Hematol Oncol"},{"key":"14552_CR28","doi-asserted-by":"publisher","unstructured":"Vasquez L, Diaz R, Chavez S, Tarrillo F, Maza I, Hernandez E et al. Factors associated with abandonment of therapy by children diagnosed with solid tumors in Peru. Pediatr Blood Cancer 2018,65(6):e27007.\u00a0https:\/\/doi.org\/10.21002\/pbc.27007. Epub 22018 Feb 27012.","DOI":"10.21002\/pbc.27007"},{"key":"14552_CR29","unstructured":"Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies. Available at: https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools"},{"key":"14552_CR30","unstructured":"National Heart, Lung, and Blood Institute. Quality assessment tool for observational cohort and cross-sectional studies. Availablr at: https:\/\/www.nhlbi.nih-gov\/healthtopics\/study-quality-assessment-tools"},{"key":"14552_CR31","doi-asserted-by":"publisher","unstructured":"Maarouf N, Mahmoud S, Khedr R, Lehmann L, Shaaban K, Ibrahim S et al. Outcome of childhood acute megakaryoblastic leukemia: children\u2019s Cancer hospital Egypt 57357 experience. Clin Lymphoma Myeloma Leuk:https:\/\/doi.org\/10.1016\/j.clml.2018.1012.1011","DOI":"10.1016\/j.clml.2018.1012.1011"},{"key":"14552_CR32","doi-asserted-by":"publisher","unstructured":"Mamo W, Moges A, Yesuf SA, Mohamedsaid A, Arega G. Treatment outcomes of pediatrics acute myeloid leukemia (AML) and associated factors in the country\u2019s tertiary referral hospital, Ethiopia. BMC Cancer 2024, 24:640. https:\/\/doi.org\/10.1186\/s12885-12024-12404-12885.","DOI":"10.1186\/s12885-12024-12404-12885"},{"key":"14552_CR33","doi-asserted-by":"publisher","unstructured":"Nzamu I, Ssenyondwa J, Naitala R, Akullo A. Feasibility of evidence-based treatment of childhood acute myeloid leukemia in a Sub-Sahara Africa center. J Clin Oncol. 2020;38(e22508\u2013e22508). https:\/\/doi.org\/10.21200\/JCO.22020.22538.22515_suppl.e22508.","DOI":"10.21200\/JCO.22020.22538.22515_suppl.e22508"},{"key":"14552_CR34","unstructured":"Rika Leonora de Jager, Bassingthwaighte M. A Retrospective review of paediatric acute myeloid leukaemia at Chris Hani Baragwanath Academic Hospital in Johannesburg, South Africa. Accessed April 21, 2024. Available at https:\/\/hdl.handle.net\/10539\/34428. 2022."},{"key":"14552_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2020.1004.1011","author":"SF Semary","year":"2020","unstructured":"Semary SF, Hammad M, Soliman S, Yassen D, Gamal M, Albeltagy D, et al. Outcome of childhood acute myeloid leukemia with FLT3-ITD mutation: the experience of children\u2019s Cancer hospital egypt, 2007-17. Clin Lymphoma Myeloma Leuk. 2020. https:\/\/doi.org\/10.1016\/j.clml.2020.1004.1011.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"14552_CR36","doi-asserted-by":"publisher","unstructured":"van Weelderen RE, Wijnen NE, Njuguna F et al. Treatment outcomes of pediatric acute myeloid leukemia in Western Kenya before and after the implementation of the SIOP PODC treatment guideline. Cancer Reports 2023, 6(8):e1849. https:\/\/doi.org\/10.1002\/cnr1842.1849.","DOI":"10.1002\/cnr1842.1849"},{"key":"14552_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2174\/1874079001407010007","volume":"7","author":"S Cherkaoui","year":"2014","unstructured":"Cherkaoui S, Bendari M, Madani A, Quessar A, Benchekroun S. Acute megakaryoblastic leukemia in children: diagnosis and management challenges in resource-poor countries. Open Cancer J. 2014;7:7\u201310.","journal-title":"Open Cancer J"},{"issue":"2","key":"14552_CR38","doi-asserted-by":"publisher","first-page":"93","DOI":"10.7196\/SAJCH.2023.v7117i7192.1944","volume":"17","author":"S Ndlovu","year":"2023","unstructured":"Ndlovu S, Esterhuizen TM, Uys U, van Zyl A, Kruger M. Trends in childhood cancers at Tygerberg hospital from 1994 to 2014. SAJCH. 2023;17(2):93\u20138. https:\/\/doi.org\/10.7196\/SAJCH.2023.v7117i7192.1944.","journal-title":"SAJCH"},{"issue":"4","key":"14552_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22270\/jddt.v22210i22274.24202","volume":"10","author":"SK Beghdoud","year":"2020","unstructured":"Beghdoud SK, Youcef C, Diaf M, Boumedane A. Comparison of clinical, biological and evolutionary characteristics between childhood acute lymphoblastic and myeloid leukemia in Western algeria, from 2016 to 2018. J Drug Delivery Ther. 2020;10(4):1\u20137. https:\/\/doi.org\/10.22270\/jddt.v22210i22274.24202.","journal-title":"J Drug Delivery Ther"},{"issue":"1","key":"14552_CR40","first-page":"1","volume":"9","author":"AM Ali","year":"2012","unstructured":"Ali AM, Morsy AM, Ahmed EH, Elaleem AA. Clinical outcome of pediatric acute myeloid leukemia treated at South Egypt Cancer institute, Assiut university, Egypt. SECI Oncol. 2012;9(1):1\u20137.","journal-title":"SECI Oncol"},{"issue":"S1","key":"14552_CR41","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1097\/1001.HS1099.00005625.0000550917.df","volume":"3","author":"Y Madney","year":"2019","unstructured":"Madney Y, Ezzelden N, Elsharkawy N. Pediatric acute myeloid leukemia (AML) in developing countries, barriers against better outcome 10 years\u2019 experience among Egyptian pediatric acute myeloid leukemia. HamaSphere. 2019;3(S1):480\u20131. 410.1097\/1001.HS1099.0000562544.0000550917.df.","journal-title":"HamaSphere"},{"key":"14552_CR42","doi-asserted-by":"publisher","unstructured":"Semary S, Hammad M, Yassin D, N ES, Soliman S, Salem S et al. Acute promyelocytic leukemia in children cancer hospital Egypt. Discover Oncology 2024,15(1):223.\u00a0https:\/\/doi.org\/10.1007\/s12672-12024-01037-12676.","DOI":"10.1007\/s12672-12024-01037-12676"},{"issue":"2","key":"14552_CR43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.36346\/sarjams.32019.v36301i36302.36001","volume":"1","author":"PAH Ongotsoyi","year":"2019","unstructured":"Ongotsoyi PAH, Kengang KBA, Koum KD, Leverger G, Nkolata A, Nonga N. Management of acute myeloblastic leukemias: the experience of the mother and child center of chantal Biya foundation, Yaounde. South Asian Res J App Med Sci. 2019;1(2):25\u201331. https:\/\/doi.org\/10.36346\/sarjams.32019.v36301i36302.36001.","journal-title":"South Asian Res J App Med Sci"},{"issue":"22","key":"14552_CR44","doi-asserted-by":"publisher","first-page":"5176","DOI":"10.1182\/blood.V128.22.5176.5176","volume":"128","author":"B Houssou","year":"2016","unstructured":"Houssou B, Lamchahab M, Massi R, Khoubila N, Cherkaoui S, Qachouh M, et al. Outcome of acute myeloid leukemia in children and young adults treated with an uniform protocol in Casablanca, Morocco. Blood. 2016;128(22):5176\u20135176. https:\/\/doi.org\/10.1182\/blood.V128.22.5176.5176.","journal-title":"Blood"},{"key":"14552_CR45","doi-asserted-by":"publisher","unstructured":"Jeddi R, He`la` Ghe\u00b4dira, Abdennebi YB, Kacem K, Amor RB, Aissaoui L et al. ATRA and anthracycline-based chemotherapy in the treatment of childhood acute promyelocytic leukemia (APL): A 10-year experience in Tunisia. Med Oncol 2011, 28:1618\u20131623. https:\/\/doi.org\/10.1007\/s12032-12010-19642-12039.","DOI":"10.1007\/s12032-12010-19642-12039"},{"issue":"23","key":"14552_CR46","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.1182\/blood.V126.23.4898.4898","volume":"126","author":"N Chellakhi","year":"2015","unstructured":"Chellakhi N, Khoubila N, Cherkaoui S, Madani A, Athale U, Quessar AAQ. Acute myeloid leukaemia in children: preliminary results of a national protocol in Casablanca, Morocco. Blood. 2015;126(23):4898\u20134898.","journal-title":"Blood"},{"key":"14552_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2020.104597","volume":"118","author":"EZ Kandeel","year":"2021","unstructured":"Kandeel EZ, Madney Y, Eldin DN, Shafik NF. Overexpression of CD200 and CD123 is a major influential factor in the clinical course of pediatric acute myeloid leukemia. Exp Mol Pathol. 2021;118: 104597.","journal-title":"Exp Mol Pathol"},{"issue":"23","key":"14552_CR48","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.1182\/blood.V126.23.4891.4891","volume":"126","author":"I Marielle","year":"2015","unstructured":"Marielle I, Lamchaheb M, Khoubila N, Cherkaoui S, Oukache B, Hda N, et al. Favorable risk group acute myeloid leukemia in children and young adult treated in uniform protocol in Casablanca, Morocco. A preliminary analysis. Blood. 2015;126(23):4891\u20134891.","journal-title":"Blood"},{"key":"14552_CR49","doi-asserted-by":"publisher","unstructured":"Rasche M, Zimmermann M, Borschel L, et al. Successes and challenges in the treatment of paediatric acute myeloid leukaemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012. Leukemia. 2018;32(10):2167\u201377. https:\/\/doi.org\/10.1038\/s41375-018-0071-7.","DOI":"10.1038\/s41375-018-0071-7"},{"key":"14552_CR50","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1365-2141.2010.08389.x","volume":"151","author":"L Molgaard-Hansen","year":"2010","unstructured":"Molgaard-Hansen L, Mottonen M, Glosli H, et al. Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984\u20132003. Br J Haematol. 2010;151:447\u201359.","journal-title":"Br J Haematol"},{"issue":"21","key":"14552_CR51","doi-asserted-by":"publisher","first-page":"4384","DOI":"10.1200\/JCO.2004.01.191","volume":"22","author":"U Creutzig","year":"2004","unstructured":"Creutzig U, Zimmermann M, Reinhardt D, et al. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukaemia: analysis of the multicentre clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol. 2004;22(21):4384\u201393.","journal-title":"J Clin Oncol"},{"key":"14552_CR52","doi-asserted-by":"publisher","unstructured":"Webb DK, Harrison G, Stevens RF, Gibson BG, Hann IM, Wheat-ley K et al. Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML10 and 12 trials for acute myeloid leukemia. Blood 2001(98):1714\u20131720.\u00a0https:\/\/doi.org\/10.1182\/blood.v1798.1716.1714.","DOI":"10.1182\/blood.v1798.1716.1714"},{"key":"14552_CR53","doi-asserted-by":"publisher","unstructured":"de Morais RV, de Souza MV, de Souza Silva KA, Santiago P, Lorenzoni MC, Lorea CF et al. Epidemiological evaluation and survival of children with acute myeloid leukemia. Jornal de Pediatria 2021, 97(2):204\u2013210.\u00a0https:\/\/doi.org\/10.1016\/j.jped.2020.1002.1003.","DOI":"10.1016\/j.jped.2020.1002.1003"},{"key":"14552_CR54","doi-asserted-by":"publisher","unstructured":"de Morais RV, de Souza MV, de Souza Silva KA, Santiago P, Lorenzoni MC, Lorea CF et al. Epidemiological evaluation and survival of children with acute myeloid leukemia. Jornal de Pediatria 2021, 97(2):204\u2013210. https:\/\/doi.org\/10.1016\/j.jped.2020.1002.1003.","DOI":"10.1016\/j.jped.2020.1002.1003"},{"issue":"4","key":"14552_CR55","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.htct.2023.08.006","volume":"46","author":"AA Franco","year":"2024","unstructured":"Franco AA, Lotero V, Rodr\u00edguez P, Beltran E, Manzi E, Devia-Zapata A, et al. Outcomes and challenges treating pediatric acute myeloid leukemia: a retrospective analysis of patients treated at the Fundacion Valle Del Lili between 2011 and 2020. Hematol Transfus Cell Ther. 2024;46(4):420\u20137.","journal-title":"Hematol Transfus Cell Ther"},{"key":"14552_CR56","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/940278","author":"E Jim\u00e9nez- Hern\u00e1ndez","year":"2015","unstructured":"Jim\u00e9nez-Hern\u00e1ndez E, Due\u00f1as-Gonz\u00e1lez MT, Arellano-Galindo J, Medrano-Ort\u00edz-De-Z\u00e1rate ME, Bekker-M\u00e9ndez VC, Berges-Garc\u00eda A, et al. Survival of Mexican children with acute myeloid leukaemia who received early intensification chemotherapy and an autologous transplant. BioMed Res Int. 2015. https:\/\/doi.org\/10.1155\/2015\/940278.","journal-title":"BioMed Res Int"},{"key":"14552_CR57","doi-asserted-by":"publisher","unstructured":"Srinivasan S, Bolous NS, Batra A, Bharti S, Singh N, Shaikh T, et al. Cost-effectiveness of treating childhood acutemyeloid leukemia at a tertiary care center in North India. Pediatr Blood Cancer. 2024(11). https:\/\/doi.org\/10.1002\/pbc.31242.","DOI":"10.1002\/pbc.31242"},{"key":"14552_CR58","doi-asserted-by":"publisher","unstructured":"Ghafoor T, Sharif I, Ashraf T, Ahmed S, Bashir F. Paediatric acute myeloid leukaemia; clinical characteristics and treatment outcome; experience from a developing country. Int J Adv Res 2018, 6(11):113\u2013122. https:\/\/doi.org\/10.21474\/IJAR21401\/27977.","DOI":"10.21474\/IJAR21401\/27977"},{"key":"14552_CR59","doi-asserted-by":"publisher","unstructured":"Kulkarni KP. Ram Kumar Marwaha: Childhood Acute Myeloid Leukemia: An Indian Perspective. Pediatric Hematology and Oncology 2011, 28:257\u2013268. https:\/\/doi.org\/10.3109\/08880018.08882010.08531521.","DOI":"10.3109\/08880018.08882010.08531521"},{"key":"14552_CR60","doi-asserted-by":"publisher","unstructured":"Hjalgrim LL, Rostgaard K, Schmiegelow K, So\u00a8derha\u00a8ll S, Kolmannskog S, Vettenranta K et al. Age- and Sex-Specific Incidence of Childhood Leukemia by Immunophenotype in the Nordic Countries. J Natl Cancer Inst 2003, 95(20):1539\u20131544.\u00a0https:\/\/doi.org\/10.1093\/jnci\/djg1064.","DOI":"10.1093\/jnci\/djg1064"},{"key":"14552_CR61","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/bjh.12030","volume":"159","author":"T Imamura","year":"2012","unstructured":"Imamura T, Iwamoto S, Kanai R, Shimada A, Terui K, et al. Outcome in 146 patients with paediatric acute myeloid leukaemia treated according to the AML99 protocol in the period 2003\u201306 from the Japan Association of Childhood Leukaemia Study. Br J Haematol. 2012;159:204\u201310. https:\/\/doi.org\/10.1111\/bjh.12030.","journal-title":"Br J Haematol"},{"key":"14552_CR62","doi-asserted-by":"publisher","unstructured":"de Melo Rodrigues AL, Lenzi L, Lee-Jones L, Wanderley AV, AMM DS. CR DC,: Acute myeloid leukemia in children and adolescents in Brazilian institutions: reality and challenges. J Bone Marrow Transplantation Cell Therapy:77\u201386. https:\/\/doi.org\/10.46765\/42675-46374X.42020v46762n46761p46777-46786","DOI":"10.46765\/42675-46374X.42020v46762n46761p46777-46786"},{"key":"14552_CR63","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s11899-010-0060-z","volume":"5","author":"M Radhi","year":"2010","unstructured":"Radhi M, Meshinchi S, Gamis A. Prognostic factors in pediatric acutemyeloid leukemia. Curr Hematol Malig Rep. 2010;5:200\u20136.","journal-title":"Curr Hematol Malig Rep"},{"key":"14552_CR64","doi-asserted-by":"publisher","unstructured":"Van Der Velden VH, Van Der Sluijs-Geling A, Gibson BE, te Marvelde JG, Hoogeveen PG, Hop WCJ et al. Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97\/MRC AML12 protocol. Leukemia 2010;24(9):1599\u20131606. https:\/\/doi.org\/10.1038\/leu.2010.1153. Epub 2010 Jul 1529.","DOI":"10.1038\/leu.2010.1153"},{"key":"14552_CR65","doi-asserted-by":"publisher","unstructured":"Creutzig U, Van Den Heuvel-eibrink MM, Gibson B, Dworzak MN, Adachi S, de Bont E et al. Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel. Blood 2012;120(16):3187\u20133205. doi: https:\/\/doi.org\/10.1182\/blood-2012-3103-362608.","DOI":"10.1182\/blood-2012-3103-362608"},{"key":"14552_CR66","doi-asserted-by":"publisher","unstructured":"Bitan M, He W, Mei-Jie Z, Abdel-Azim H, Ayas MF, Bielorai B et al. Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens. Blood 2014;123(10):1615\u20131620. doi: https:\/\/doi.org\/10.1182\/blood-2013-1610-535716.","DOI":"10.1182\/blood-2013-1610-535716"},{"issue":"7","key":"14552_CR67","first-page":"2405","volume":"96","author":"MS Tallman","year":"2000","unstructured":"Tallman MS, Neuberg D, Bennett JM, Francois CJ, Paietta E, Wiernik PH, et al. Acute megakaryocytic leukemia: the Eastern cooperative oncology group experience. Blood. 2000;96(7):2405\u201311.","journal-title":"Blood"},{"key":"14552_CR68","doi-asserted-by":"publisher","unstructured":"Ruiz-Arguelles GJ, Lobato-Mendizabal E, San-Miguel JF, Gonz\u00e1lez M, Caballero MD, Ruiz-Arg\u00fcelles AR et al. Long-term treatment results for acute megakaryoblastic leukemia patients: a multicentre study. Br J Haematol 1992;82(4):671\u2013675. doi: https:\/\/doi.org\/10.1111\/j.1365-2141.1992.tb06942.x.","DOI":"10.1111\/j.1365-2141.1992.tb06942.x"},{"issue":"1","key":"14552_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40272-40016-40200-40276","volume":"19","author":"JE Rubnitz","year":"2017","unstructured":"Rubnitz JE. Current management of childhood acute myeloid leukemia. Paediatr Drugs. Feb; 2017;19(1):1\u201310. https:\/\/doi.org\/10.1007\/s40272-40016-40200-40276.","journal-title":"Paediatr Drugs"},{"key":"14552_CR70","doi-asserted-by":"publisher","unstructured":"Klein K, Van Litsenburg RRL, De Haas V, Dors N, van den Heuvel-Eibrink MM, Knops RRG et al. Causes of early death and treatment-related death in newly diagnosed pediatric acute myeloid leukemia: Recent experiences of the Dutch Childhood Oncology Group. Pediatr Blood Cancer 2020;67(4):e28099. https:\/\/doi.org\/10.21002\/pbc.28099.","DOI":"10.21002\/pbc.28099"},{"key":"14552_CR71","doi-asserted-by":"publisher","unstructured":"Creutzig U, Zimmermann M, Reinhardt D, Dworzak M, Stary J, Lehrnbecher T. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol 2004;22(21):4384\u20134393. https:\/\/doi.org\/10.1200\/JCO.2004.4301.4191.","DOI":"10.1200\/JCO.2004.4301.4191"},{"key":"14552_CR72","doi-asserted-by":"publisher","unstructured":"Von Neuhoff C, Reinhardt D, Sander A, Zimmermann M, Bradtke J, Betts DR et al. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98. J Clin Oncol 2010, 28(16):2682\u20132689. https:\/\/doi.org\/10.1200\/JCO.2009.2625.6321.","DOI":"10.1200\/JCO.2009.2625.6321"},{"key":"14552_CR73","doi-asserted-by":"publisher","unstructured":"Pui CH, Caroll WL, Meshinchi S, Arceci RJ. Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol 2011, 29(5):551\u2013565. https:\/\/doi.org\/10.1200\/JCO.2010.1230.7405.","DOI":"10.1200\/JCO.2010.1230.7405"},{"key":"14552_CR74","doi-asserted-by":"crossref","unstructured":"Nasution F, Arifin Z, Sutjipto A. Acute non lymphoblastic leukemia in the department of child health school of medicine, university of North Sumatera\/Dr. Pirngadi hospital Medan (1983\u20131988), a preliminary study. Paediatr Indones 1991, 31(9\u201310):268\u2013272. 10.14238\/pi14231.14239-14210.11991.14268-14272.","DOI":"10.14238\/pi31.9-10.1991.268-72"},{"key":"14552_CR75","doi-asserted-by":"publisher","unstructured":"Gibson BES, Webb DKH, Howman AJ, De Graaf SS, Harrison CJ, Wheatley K. Results of a randomized trial in children with acute myeloid leukaemia: medical research council AML12 trial. Br J Haematol 2011, 155(3):366\u2013376. https:\/\/doi.org\/10.1111\/j.1365-2141.2011.08851.x.","DOI":"10.1111\/j.1365-2141.2011.08851.x"},{"key":"14552_CR76","doi-asserted-by":"publisher","unstructured":"Yadav SP, Ramzan M, Lall M, Sachdeva A. Pediatric acute myeloid leukemia: final frontier for pediatric oncologists in developing world. Pediatr Hematol Oncol 2011, Nov;28(8):647\u2013648. https:\/\/doi.org\/10.3109\/08880018.08882011.08601435.","DOI":"10.3109\/08880018.08882011.08601435"},{"key":"14552_CR77","doi-asserted-by":"publisher","unstructured":"Creutzig U, van den Heuvel-Eibrink MM, Gibson B et al. Diagnosis and management of acute myeloid leukaemia in children and adolescents: recommendations from an international expert panel. Blood 2012, 120(16):3187\u20133205. https:\/\/doi.org\/10.1182\/blood-2012-3103-362608.","DOI":"10.1182\/blood-2012-3103-362608"},{"key":"14552_CR78","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1055\/s-0042-1754370","volume":"43","author":"S Srinivasan","year":"2022","unstructured":"Srinivasan S, Gollamudi VRM, Dhariwal N. Pediatric acute myeloid leukemia in India: a systematic review. Indian J Med Paediatr Oncol. 2022;43:342\u20138. https:\/\/doi.org\/10.1055\/s-0042-1754370.","journal-title":"Indian J Med Paediatr Oncol"},{"key":"14552_CR79","doi-asserted-by":"publisher","unstructured":"Sung L, Aplenc R, Alonzo TA, Gerbing RB, Lehrnbecher T, Gamis AS. Effectiveness of supportive care measures to reduce infections in pediatric AML: a report from the Children\u2019s Oncology Group. Blood 2013, May 2;121(18):3573\u20133577. https:\/\/doi.org\/10.1182\/blood-2013-3501-476614.","DOI":"10.1182\/blood-2013-3501-476614"},{"key":"14552_CR80","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4103\/2278-330X.187591","volume":"5","author":"RS Arora","year":"2016","unstructured":"Arora RS, Arora B. Acute leukemia in children: A review of the current Indian data. South Asian J Cancer. 2016;5:155\u201360.","journal-title":"South Asian J Cancer"},{"key":"14552_CR81","doi-asserted-by":"publisher","unstructured":"Bansal D, Davidson A, Supriyadi E, Njuguna F, Ribeiro RC, GJL. K.: SIOP PODC adapted risk stratification and treatment guidelines: Recommendations for acute myeloid leukemia in resource-limited settings. Pediatr Blood Cancer 2019:e28087. https:\/\/doi.org\/10.21002\/pbc.28087.","DOI":"10.21002\/pbc.28087"},{"key":"14552_CR82","doi-asserted-by":"publisher","unstructured":"Howard SC, Davidson A, Luna-Fineman S et al. A framework to develop adapted treatment regimens to manage pediatric cancer in low- and middle-income countries: the Pediatric Oncology inDeveloping Countries (PODC)Committee of the International Pediatric Oncology Society (SIOP). Pediatr Blood Cancer 2017, 64(Suppl 5):e26879. https:\/\/doi.org\/10.21002\/pbc.26879.","DOI":"10.21002\/pbc.26879"},{"key":"14552_CR83","doi-asserted-by":"publisher","unstructured":"Hong D, Zhou C, He H, Wang Y, Lu J, Hu S. A 10-Year Follow-up Survey of Treatment Abandonment of Children With Acute Myeloid Leukemia in Suzhou, China. J Pediatr Hematol Oncol 2016, Aug;38(6):437\u2013442. https:\/\/doi.org\/10.1097\/MPH.0000000000000601.0000000000000652.","DOI":"10.1097\/MPH.0000000000000601.0000000000000652."},{"key":"14552_CR84","doi-asserted-by":"publisher","unstructured":"Mostert S, Arora RS, Arreola M, Bagai P, Friedrich P, Gupta S et al. Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working Group. Lancet Oncol 2011, Aug;12(8):719\u2013720. https:\/\/doi.org\/10.1016\/S1470-2045(1011)70128-70120.","DOI":"10.1016\/S1470-2045(1011)70128-70120"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14552-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14552-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14552-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T20:03:26Z","timestamp":1751659406000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14552-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14552"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14552-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]},"assertion":[{"value":"20 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to\u00a0participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1140"}}